Saturday 17 October 2026
Export ACOG’s income statement to Excel — free account
Alpha Cognition Inc.
ACOG Healthcare Biotechnology
Alpha Cognition Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.2 million. In the quarter to June 2026, revenue grew 267.6%, EPS grew 38.5% and free cash flow fell 109.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
8.19
0.26
−3.08%
Follow ACOG
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(142.30%) | (40.68%) | (51.74%) | (49.53%) | |
| (85.93%) | (31.69%) | (43.14%) | (38.33%) | ||
ROIC |
0.00% | 0.00% | (542.73%) | (144.65%) | |
Return on Tangible Assets |
(56.44%) | (29.44%) | (40.08%) | (40.50%) | |
Average Days of Receivables |
0.00 | 151.28 | 120.65 | 130.95 | |
Free Cash Flow per Share |
(0.99) | (1.17) | (1.40) | (1.70) | |
Free Cash Flow |
(15.95) | (20.67) | (30.37) | (37.08) | |
Capital Expenditures |
(0.17) | (0.29) | (0.23) | (6.23) | |
| Other line items | |||||
Cash ROIC |
(22.99%) | (16.07%) | (27.17%) | (39.28%) | |
Accounts Receivable Turnover |
0.00 | 4.76 | 5.41 | 4.19 | |
Accounts Payable Turnover |
0.00 | 0.34 | 0.34 | 0.32 | |
Inventory Turnover |
— | 0.67 | 0.39 | 0.40 | |
Average Days of Payables |
0.00 | 1,710.73 | 1,435.03 | 1,550.05 | |
Days of Inventory on Hand |
0.00 | 976.39 | 1,633.31 | 1,589.01 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 18.28% | 23.68% | 27.30% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 284.49% | 316.30% | 237.18% | |
Share Based Compensation of Revenue |
0.00% | 48.16% | 43.18% | 13.86% | |
Interest Coverage |
65.21 | — | — | — | |
Operating CF/Net income |
0.72 | 0.99 | 1.19 | 1.47 | |
Depreciation/Fixed assets |
0.26 | 0.18 | 0.27 | 0.46 | |
Capex/Depreciation |
(3.33) | (5.01) | (2.85) | (35.98) | |
Revenue per Share |
0.00 | 0.58 | 0.50 | 0.70 | |
Operating CF per Share |
(0.98) | (1.15) | (1.38) | (1.42) | |
Capex per Share |
(0.01) | (0.02) | (0.01) | (0.29) | |
Capex to Sales |
0.00 | 0.03 | 0.02 | 0.41 |
Columns are period end dates